Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.
By A. Hildesheim, R. Herrero, S. Wacholder, A. Rodriguez, D. Solomon, M. Bratti, J. Schiller, Paula González, G. Dubin, C. Porras and 3 more. Journal of the American Medical Association (JAMA), 2007
635 citations recorded by the source corpus.
Subfields: Epidemiology, Microbiology, Otorhinolaryngology
View Paper: https://www.semanticscholar.org/paper/142d9dd7f4e9c17df21a52fd0adfcd41fcf243d5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Otorhinolaryngology
Citations in the corpus
- A review of clinical trials of human papillomavirus prophylactic vaccines. (2012, background): “There was no difference in the rate of clearance of vaccine or non-vaccine types in Cervarix® vaccinees and control [37].”